Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Amant

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Gynecologic Oncology|April 2, 2002
PTEN mutations in uterine sarcomasF Amant, M de la Rey, C M Dorfling, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 23, 2006
New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonographyF De Smet, J De Brabanter, T Van den Bosch, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancerN M de Lange, N P M Ezendam, J S Kwon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Eclinicalmedicine|December 9, 2020
The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysisJ Blommaert, A Radwan, C Sleurs, et al.
Gynecologic Oncology|October 10, 2013
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in BelgiumJ Werbrouck, G Bouche, E de Jonge, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of viewP Neven, R Paridaens, F Amant, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 29, 2005
Ultrasound features of different histopathological subtypes of borderline ovarian tumorsE Fruscella, A C Testa, G Ferrandina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Gynecologic Oncology|April 2, 2002
PTEN mutations in uterine sarcomasF Amant, M de la Rey, C M Dorfling, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 23, 2006
New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonographyF De Smet, J De Brabanter, T Van den Bosch, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancerN M de Lange, N P M Ezendam, J S Kwon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Eclinicalmedicine|December 9, 2020
The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysisJ Blommaert, A Radwan, C Sleurs, et al.
Gynecologic Oncology|October 10, 2013
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in BelgiumJ Werbrouck, G Bouche, E de Jonge, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of viewP Neven, R Paridaens, F Amant, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 29, 2005
Ultrasound features of different histopathological subtypes of borderline ovarian tumorsE Fruscella, A C Testa, G Ferrandina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2010
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers, P Neven, M R Christiaens, et al.
Pageof 13